Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of inhaled ethanol for early-stage COVID-19
2020-001760-29Phase 2Terminated
- Sponsor
- Sociedad Española de Farmacia Hospitalaria
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ethanol in coronavirus disease 2019 (COVID-19), sponsored by Sociedad Española de Farmacia Hospitalaria. Primary endpoint: Progression to severe COVID-19. Started Nov 2020; status: terminated.
02
Drugs
ethanol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001760-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001760-29.